BR0309111A - Método para a sìntese de beta-l-5-fluoro-2' ,3' -dideóxi - 2' ,3' -dideidrocitidina - Google Patents

Método para a sìntese de beta-l-5-fluoro-2' ,3' -dideóxi - 2' ,3' -dideidrocitidina

Info

Publication number
BR0309111A
BR0309111A BR0309111-2A BR0309111A BR0309111A BR 0309111 A BR0309111 A BR 0309111A BR 0309111 A BR0309111 A BR 0309111A BR 0309111 A BR0309111 A BR 0309111A
Authority
BR
Brazil
Prior art keywords
dideoxy
fluoro
synthesis
beta
dehydrocytidine
Prior art date
Application number
BR0309111-2A
Other languages
English (en)
Inventor
Bo Kowalczyk
Li Zhao
Ralph M Schure
Lisa Dunkle
Original Assignee
Achillion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Achillion Pharmaceuticals Inc filed Critical Achillion Pharmaceuticals Inc
Publication of BR0309111A publication Critical patent/BR0309111A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048—Pyridine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

"MéTODO PARA A SìNTESE DE BETA-L-5-FLUORO-2,<39>,3<39>-DIDEóXI-2<39>,3<39>-DIDEID ROCITIDINA". A invenção apresenta um método para a síntese de <225>-L-5-fluoro-2<39>,3<39>-dideóxi-2<39>,3<39>-dideidrocitidin a (<225>-L-FD4C). O método permite a produção em larga escala de <225>-L-FD4C de uma forma eficiente, eficiente em custo, e saudável do ponto de vista ambiental.
BR0309111-2A 2002-04-12 2003-04-11 Método para a sìntese de beta-l-5-fluoro-2' ,3' -dideóxi - 2' ,3' -dideidrocitidina BR0309111A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37200602P 2002-04-12 2002-04-12
PCT/US2003/011445 WO2003087119A1 (en) 2002-04-12 2003-04-11 METHOD FOR SYNTHESIZING β-L-FLUORO-2´,3´DIDEHYDROCYTIDINE (β-L-FD4C)

Publications (1)

Publication Number Publication Date
BR0309111A true BR0309111A (pt) 2005-02-01

Family

ID=29250776

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309111-2A BR0309111A (pt) 2002-04-12 2003-04-11 Método para a sìntese de beta-l-5-fluoro-2' ,3' -dideóxi - 2' ,3' -dideidrocitidina

Country Status (14)

Country Link
US (1) US6897302B2 (pt)
EP (1) EP1495040A4 (pt)
JP (1) JP2005527589A (pt)
KR (1) KR20050005442A (pt)
CN (1) CN1329407C (pt)
AU (1) AU2003234737B2 (pt)
BR (1) BR0309111A (pt)
CA (1) CA2481572A1 (pt)
MX (1) MXPA04009986A (pt)
NO (1) NO20044927L (pt)
PL (1) PL371913A1 (pt)
RU (1) RU2310661C2 (pt)
UA (1) UA77291C2 (pt)
WO (1) WO2003087119A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ582536A (en) * 2007-07-26 2012-01-12 Lexicon Pharmaceuticals Inc Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
EP2562162B1 (en) * 2008-01-22 2015-08-19 Dow AgroSciences LLC N-cyano-4-amino-5-fluoro-pyrimidine derivatives as fungicides
EA027929B1 (ru) 2012-05-25 2017-09-29 Янссен Сайенсиз Айрлэнд Юси Нуклеозиды на основе урацила и спирооксетана

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
IL100965A (en) 1991-02-22 1999-12-31 Univ Emory 2 - Hydroxymethyl - 5 -) 5 - Fluorocytocin - 1 - Eyal (- 1, 3 - Oxathiolane, its resolution and pharmaceuticals containing it
TW374087B (en) 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
US5627160A (en) 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
US5703058A (en) 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
US6005097A (en) * 1996-06-14 1999-12-21 Vion Pharmaceuticals, Inc. Processes for high-yield diastereoselective synthesis of dideoxynucleosides
US6280940B1 (en) 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
AU5578099A (en) 1998-08-25 2000-03-14 National Taiwan University Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin andits analogs
HUP0500456A3 (en) 2000-11-20 2012-05-02 Bristol Myers Squibb Co Hepatitis c tripeptide inhibitors, pharmaceutical compositions comprising thereof and their use
WO2002057287A2 (en) 2001-01-22 2002-07-25 Merck & Co., Inc. Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
US6689559B2 (en) 2001-11-29 2004-02-10 The Research Foundation Of The State University Of New York Efficient hepatitis C virus replicon and its use in identifying antiviral compounds

Also Published As

Publication number Publication date
RU2310661C2 (ru) 2007-11-20
KR20050005442A (ko) 2005-01-13
JP2005527589A (ja) 2005-09-15
AU2003234737B2 (en) 2009-08-27
CN1653078A (zh) 2005-08-10
AU2003234737A1 (en) 2003-10-27
EP1495040A4 (en) 2006-01-25
NO20044927L (no) 2005-01-10
UA77291C2 (en) 2006-11-15
CA2481572A1 (en) 2003-10-23
MXPA04009986A (es) 2005-08-16
EP1495040A1 (en) 2005-01-12
CN1329407C (zh) 2007-08-01
US20040147479A1 (en) 2004-07-29
WO2003087119A1 (en) 2003-10-23
US6897302B2 (en) 2005-05-24
PL371913A1 (en) 2005-07-11
RU2004133062A (ru) 2005-06-10

Similar Documents

Publication Publication Date Title
NO20071309L (no) Fremgangsmate for ekspansjon
GB2421262B (en) Expandable tubular
DK1543002T3 (da) Fremstilling af 1H-imidazo (4,5-c) quinolin-4-aminer via 1H-imidazo (4,5-c) quinolin-4-phtalimid mellemprodukter
TW200707466A (en) Conductive patterning
SG145694A1 (en) Novel compounds
MXPA05013202A (es) Tableta de multiples capas oralmente dispersable.
NO20032273D0 (no) Driversammensetning for akustiske kilder
DE50310977D1 (de) Kompaktiertes menthol
AU2003227902A1 (en) Millimetre-wave illumination source
SG148154A1 (en) Benzannelated compounds as ppar activators
AP2005003242A0 (en) Broadspectrum 2-aminobenzothiazole sulfonamide HIVprotease inhibitors.
BR0309111A (pt) Método para a sìntese de beta-l-5-fluoro-2&#39; ,3&#39; -dideóxi - 2&#39; ,3&#39; -dideidrocitidina
GB0222143D0 (en) Adaptive predictive playout scheme for pocket voice applications
MXPA05011169A (es) Metodo para sintetizar derivados de 5-cloro-1-aril-4 -(4, 5-diciano- 1h-imidazol-2-il)- 3-alquil -1h-pirazola.
BR0317068B1 (pt) mÉtodo para produÇço de Álcool.
ITMI20030042A1 (it) Processo di sintesi enzimatica di antibiotici b lattamici.
BRPI0307722A2 (pt) microorganismo envolvido
ITRM20020140U1 (it) Mobile per tastiera musicale elettronica.
CY1115144T1 (el) Παραγωγα του uk-2a
UY34598A (es) Antranilamidas insecticidas
ITMI20022273A1 (it) Sintesi enzimatica di (s)-1, 2-0-1, 2-0-isopropilidenglicerolo.
UA6802S (uk) Емблема для аудіопродукції
FI20021421A0 (fi) Valmistusmenetelmä
ITMI20021871A1 (it) Vassoio e relativo metodo di produzione.
AU2002952122A0 (en) Business process for renewable fuel source

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2156 DE 02/05/2012.